Aptar Pharma launched its new DF30Plus metering valve, an extension of its DF30 line, at DDL 22. According to the company, the new valve is more compatible with a wide range of formulations, including those containing ethanol, and also has “ultra-low extractable levels” and “excellent pressure filling capability.”
Aptar Pharma Prescription Division’s Associate Director, Business Development Chris Baron commented, “At Aptar Pharma, we are extremely pleased to announce the launch of this new optimized metering valve. DF30Plus is the result of innovation and continuous improvement to the DF30 technology platform range and provides several new benefits. After 20 years of leading the industry in the supply of metering valves for pMDIs, we still continue to improve our high quality devices and anticipate our customers’ future needs and expectations.”
Read the Aptar press release.
